Guidant Infringes St. Jude Patent, Federal Jury Finds; Award Still Undecided
This article was originally published in The Gray Sheet
Executive SummaryGuidant infringes one of St. Jude Medical's patents for a feature of its pacemaker and defibrillator external programming software, a jury determined Dec. 16 in a Minneapolis federal court. The jury has yet to decide on the amount of damages to be awarded to St. Jude, but a decision is expected soon.
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.